Vesica Health, Inc

Vesica Health is a privately held, commercial stage company focused on the diagnosis and management of bladder cancer. Vesica has translated 20 years of advanced molecular diagnostic research in bladder cancer into well-validated, clinically actionable tests that improve the evaluation of hematuria, early detection of disease and recurrence monitoring. Vesica's patented, noninvasive urine-based AssureDx test helps physicians accurately triage hematuria patients, distinguishing patients at increased risk for bladder cancer, who may benefit from immediate referral to urology and clinical evaluation, from those at very low risk for bladder cancer, who may safely avoid invasive procedures. The ReAssureDx test helps physicians noninvasively monitor bladder cancer patients at increased risk of recurrence after initial treatment, thereby improving patient management and outcomes.